Home › Swapping MasterCard For Bristol-Myers In The Growth Portfolio
 

Keywords :   


Swapping MasterCard For Bristol-Myers In The Growth Portfolio

2015-05-18 08:25:44| Biotech - Topix.net

Back in December 2014 I decided that I wanted a portfolio strictly for high flying high growth stocks and added Celgene as the first stock in the portfolio. Since that time the portfolio has grown as high as 26 positions and is up 6.38% for 2015 compared to the 3.1% gain in the S&P 500.

Tags: growth portfolio mastercard swapping

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05Online car retailer Cazoo enters administration
21.05Sherwin-Williams Launches Pipeclad Frac-Shun ERC Technology
21.05Kosas Launches Blush Is Life Collection
21.05Avery Dennison receives APR critical guidance for HDPE plastic
21.05RAAA announces two staff promotions
21.05Fiery, Esko, and GIS team up to streamline digital press production
21.05Axalta Announces Partnership with Solera, a Global Leader in Vehicle Lifecycle Management
21.05PPG to Build New Paint and Coatings Manufacturing Facility in Tennessee
More »